No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BHST BioHarvest Sciences
- 6.100
- -0.100-1.61%
Close Dec 24 13:00 ET
105.70MMarket Cap-5.26P/E (TTM)
6.180High6.100Low9.07KVolume6.140Open6.200Pre Close55.48KTurnover0.07%Turnover RatioLossP/E (Static)17.33MShares7.70052wk High25.52P/B76.66MFloat Cap4.66052wk Low--Dividend TTM12.57MShs Float17.500Historical High--Div YieldTTM1.29%Amplitude4.025Historical Low6.115Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
BioHarvest Sciences Price Target Announced at $12.00/Share by Maxim Group
BioHarvest Sciences Initiated at Buy by Maxim Group
BioHarvest Sciences CEO Discusses Tate & Lyle Partnership - ICYMI | CSE:BHSC, NASDAQ:BHST
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules
EXCLUSIVE: BioHarvest Sciences Tells Benzinga 'New Collaboration to Pioneer Next Generation of Plant-based Ingredients for Healthier Food and Beverages'
EXCLUSIVE: BioHarvest Sciences Tells Benzinga Co. Announce A Partnership With Tate & Lyle To Drive The Future Of Ingredients Through Botanical Synthesis Technology
Heat List
US
Overall
Symbol
Price
% Chg
No Data